Literature DB >> 9494784

Epidemiology of pregnancy-induced hypertension.

J Zhang1, J Zeisler, M C Hatch, G Berkowitz.   

Abstract

Mounting evidence clearly indicates an immunologic basis for PIH, parity being the most convincing factor. Genetic susceptibility, physiologic change, and environmental influence may also modulate an individual's risk of developing PIH. Pathologic and follow-up studies further suggests further suggest that currently diagnosed PIH may actually be a heterogeneous entity comprising several disorders of different etiologies (150), such as chronic renal disease, borderline chronic hypertension, genetic susceptibility to hypertension, and genuine PIH. For many diseases, etiologic research and clinical management often go hand in hand. Unfortunately, in the case of PIH, etiologic research may have followed clinical steps too closely and have been misled. For clinical management, genuine preeclampsia and preeclampsia superimposed on chronic hypertension are treated as virtually the same: The ultimate goal is to prevent eclampsia. Because a sizable portion of PIH is probably due to chronic renal disease or latent chronic hypertension (33), and late-onset gestational hypertension is of less concern than preeclampsia, one could argue that it may not be clinically important to separate the subtypes of PIH. In etiologic research, however, by focusing on a heterogeneous outcome we have confused ourselves and hampered our progress. On the other hand, one should also realize that currently available techniques are unlikely to substantially improve our proficiency in differential diagnosis. Besides renal biopsy, which is impractical, especially in epidemiologic research, there are virtually no measures available that can distinguish genuine PIH from hypertension due to latent renal disorder, chronic hypertension, or genetic susceptibility. Until noninvasive measures with acceptable-sensitivity and specificity are available for differential diagnosis, frustration in etiologic research on PIH is likely to continue. One clue that may potentially advance our knowledge of the pathogenesis and future prevention of PIH is the finding that smoking reduces risk of PIH. Epidemiologists should transfer this knowledge to laboratory scientists.

Entities:  

Mesh:

Year:  1997        PMID: 9494784     DOI: 10.1093/oxfordjournals.epirev.a017954

Source DB:  PubMed          Journal:  Epidemiol Rev        ISSN: 0193-936X            Impact factor:   6.222


  35 in total

1.  Reproductive outcomes among women exposed to a brominated flame retardant in utero.

Authors:  Chanley M Small; Deanna Murray; Metrecia L Terrell; Michele Marcus
Journal:  Arch Environ Occup Health       Date:  2011       Impact factor: 1.663

2.  Effects of interpregnancy interval on blood pressure in consecutive pregnancies.

Authors:  Rafael T Mikolajczyk; Jun Zhang; Jessie Ford; Jagteshwar Grewal
Journal:  Am J Epidemiol       Date:  2008-05-20       Impact factor: 4.897

3.  The MDM2 promoter T309G polymorphism was associated with preeclampsia susceptibility.

Authors:  Saeedeh Salimi; Abbas Mohammadpour-Gharehbagh; Mahnaz Rezaei; Mojtaba Sajadian; Batool Teimoori; Atefeh Yazdi; Mojgan Mokhtari; Minoo Yaghmaei
Journal:  J Assist Reprod Genet       Date:  2017-05-15       Impact factor: 3.412

4.  My approach to performing a perinatal or neonatal autopsy.

Authors:  H C Wainwright
Journal:  J Clin Pathol       Date:  2006-07       Impact factor: 3.411

5.  Descriptive epidemiology of chronic hypertension, gestational hypertension, and preeclampsia in New York State, 1995-2004.

Authors:  David A Savitz; Valery A Danilack; Stephanie M Engel; Beth Elston; Heather S Lipkind
Journal:  Matern Child Health J       Date:  2014-05

6.  Impact of pregnancy-induced hypertension on stillbirth and neonatal mortality.

Authors:  Cande V Ananth; Olga Basso
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

7.  Hypertension during pregnancy is associated with coronary artery calcium independent of renal function.

Authors:  Andrea E Cassidy-Bushrow; Lawrence F Bielak; Andrew D Rule; Patrick F Sheedy; Stephen T Turner; Vesna D Garovic; Patricia A Peyser
Journal:  J Womens Health (Larchmt)       Date:  2009-10       Impact factor: 2.681

8.  Emergency Room Utilization After Medically Complicated Pregnancies: A Medicaid Claims Analysis.

Authors:  Ashley Harris; Hsien-Yen Chang; Lin Wang; Martha Sylvia; Donna Neale; David Levine; Wendy Bennett
Journal:  J Womens Health (Larchmt)       Date:  2015-07-30       Impact factor: 2.681

9.  Cardiovascular risk in women after metabolic complications in pregnancy.

Authors:  A H E M Maas; A W J van 't Hof; M J de Boer
Journal:  Neth Heart J       Date:  2007-12       Impact factor: 2.380

Review 10.  Pre-eclampsia part 1: current understanding of its pathophysiology.

Authors:  Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Lami Yeo; Roberto Romero
Journal:  Nat Rev Nephrol       Date:  2014-07-08       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.